Sio Capital Management LLC's Q2 2026 13F: 15 new positions, 31 exits
Form 13F-HR for the quarter ended Jun 30, 2026 · filed Aug 14, 2026 · 57 reported positions · accession 0001214659-26-010311
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Reduced | ICON PUB LTD CO (ICLR) | 4.9% | 2.6% | −2.3 pts | −218K sh | −71% |
| Reduced | DIANTHUS THERAPEUTICS INC (DNTH) | 4.5% | 1.0% | −3.5 pts | −311K sh | −84% |
| New | ALLOGENE THERAPEUTICS INC (ALLO) | — | 4.7% | +4.7 pts | +13.32M sh | new |
| New | GLOBUS MED INC (GMED) | — | 4.1% | +4.1 pts | +302K sh | new |
| Exited | CORCEPT THERAPEUTICS INC (CORT) | 3.9% | — | −3.9 pts | −675K sh | −100% |
| Exited | LIVANOVA PLC (LIVN) | 3.9% | — | −3.9 pts | −422K sh | −100% |
| Increased | CENCORA INC (COR) | 4.6% | 8.4% | +3.9 pts | +72,694 sh | +72% |
| New | IDEAYA BIOSCIENCES INC (IDYA) | — | 3.1% | +3.1 pts | +480K sh | new |
| New | THE CIGNA GROUP (CI) | — | 2.7% | +2.7 pts | +57,750 sh | new |
| New | VIATRIS INC (VTRS) | — | 2.6% | +2.6 pts | +954K sh | new |
| Reduced | WAYSTAR HLDG CORP (WAY) | 5.7% | 3.3% | −2.4 pts | −716K sh | −44% |
| Reduced | ANI PHARMACEUTICALS INC (ANIP) | 2.9% | 1.4% | −1.6 pts | −168K sh | −63% |
| Exited | EMBECTA CORP (EMBC) | 2.4% | — | −2.4 pts | −1.85M sh | −100% |
| Exited | ABIVAX SA (ABVX) | 2.2% | — | −2.2 pts | −136K sh | −100% |
| New | REGENERON PHARMACEUTICALS (REGN) | — | 1.9% | +1.9 pts | +18,000 sh | new |
| New | BRISTOL-MYERS SQUIBB CO (BMY) | — | 1.9% | +1.9 pts | +194K sh | new |
| New | MEDTRONIC PLC (MDT) | — | 1.9% | +1.9 pts | +143K sh | new |
| Exited | HAEMONETICS CORP MASS (HAE) | 1.8% | — | −1.8 pts | −221K sh | −100% |
| Exited | TELEFLEX INCORPORATED (TFX) | 1.6% | — | −1.6 pts | −94,800 sh | −100% |
| Exited | BIOMARIN PHARMACEUTICAL INC (BMRN) | 1.6% | — | −1.6 pts | −194K sh | −100% |
| Reduced | CELCUITY INC (CELC) | 3.2% | 2.0% | −1.2 pts | −83,821 sh | −43% |
| New | CYBIN INC (CYBN) | — | 1.5% | +1.5 pts | +1.3M sh | new |
| Exited | STRUCTURE THERAPEUTICS INC (GPCR) | 1.5% | — | −1.5 pts | −209K sh | −100% |
| Increased | SENSEONICS HLDGS INC (SENS) | 0.1% | 1.6% | +1.4 pts | +1.48M sh | +1276% |
| Exited | BIOHAVEN LTD (BHVN) | 1.4% | — | −1.4 pts | −1.16M sh | −100% |
| Exited | MONOPAR THERAPEUTICS INC (MNPR) | 1.4% | — | −1.4 pts | −174K sh | −100% |
| Exited | CRINETICS PHARMACEUTICALS IN (CRNX) | 1.3% | — | −1.3 pts | −250K sh | −100% |
| Reduced | SIONNA THERAPEUTICS INC (SION) | 1.7% | 1.0% | −0.7 pts | −167K sh | −57% |
| Exited | EDGEWISE THERAPEUTICS INC (EWTX) | 1.2% | — | −1.2 pts | −269K sh | −100% |
| Exited | COMPASS PATHWAYS PLC (CMPS) | 1.2% | — | −1.2 pts | −1.51M sh | −100% |
| New | TANGO THERAPEUTICS INC (TNGX) | — | 1.1% | +1.1 pts | +209K sh | new |
| Increased | ZIMMER BIOMET HOLDINGS INC (ZBH) | 0.8% | 1.9% | +1.1 pts | +68,832 sh | +110% |
| Increased | SANOFI SA (SNY) | 1.7% | 2.7% | +1.0 pts | +125K sh | +52% |
| Reduced | ABBOTT LABORATORIES (ABT) | 2.8% | 2.0% | −0.8 pts | −57,918 sh | −31% |
| Exited | QUIDELORTHO CORP (QDEL) | 0.9% | — | −0.9 pts | −359K sh | −100% |
| Exited | REPLIMUNE GROUP INC (REPL) | 0.8% | — | −0.8 pts | −720K sh | −100% |
| Exited | ORGANON & CO (OGN) | 0.7% | — | −0.7 pts | −866K sh | −100% |
| Reduced | VIR BIOTECHNOLOGY INC (VIR) | 1.9% | 1.9% | −0.1 pts | −423K sh | −28% |
| Increased | ORUKA THERAPEUTICS INC (ORKA) | 0.9% | 2.9% | +2.0 pts | +44,622 sh | +34% |
| Reduced | OCULAR THERAPEUTIX INC (OCUL) | 1.2% | 0.9% | −0.3 pts | −429K sh | −44% |
| Exited | DISC MEDICINE INC (IRON) | 0.6% | — | −0.6 pts | −65,203 sh | −100% |
| New | AVEANNA HEALTHCARE HLDGS INC (AVAH) | — | 0.5% | +0.5 pts | +369K sh | new |
| Reduced | ZENAS BIOPHARMA INC (ZBIO) | 0.9% | 0.9% | 0.0 pts | −123K sh | −37% |
| Exited | INTEGRA LIFESCIENCES HLDGS C (IART) | 0.5% | — | −0.5 pts | −383K sh | −100% |
| Reduced | MAXIMUS INC (MMS) | 7.1% | 6.6% | −0.5 pts | −53,558 sh | −7% |
| Increased | TYRA BIOSCIENCES INC (TYRA) | 3.3% | 3.8% | +0.5 pts | +89,876 sh | +15% |
| Increased | GSK PLC (GSK) | 3.1% | 3.9% | +0.9 pts | +50,821 sh | +13% |
| Exited | PROQR THERAPEUTICS N V (PRQR) | 0.5% | — | −0.5 pts | −1.95M sh | −100% |
| Exited | SHOULDER INNOVATIONS INC (SI) | 0.4% | — | −0.4 pts | −211K sh | −100% |
| Reduced | RAPPORT THERAPEUTICS INC (RAPP) | 1.7% | 2.2% | +0.5 pts | −59,152 sh | −16% |
The 50 largest of 77 changes, by size of the trade. Full holdings for this quarter.
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 50.1% of the equity book
Changes in the top 10 this quarter: ALLO entered · GMED entered · GSK entered · IDYA entered · ORKA entered · ICLR left · DNTH left · CORT left · LIVN left · CELC left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | ANTERIS TECHNOLOGIES GLOBAL (AVR) | 4.3% | 9.4% | |
| 2 | CENCORA INC (COR) | 4.6% | 8.4% | |
| 3 | MAXIMUS INC (MMS) | 7.1% | 6.6% | |
| 4 | ALLOGENE THERAPEUTICS INC (ALLO) | 0.0% | 4.7% | Entered the top 10 |
| 5 | GLOBUS MED INC (GMED) | 0.0% | 4.1% | Entered the top 10 |
| 6 | GSK PLC (GSK) | 3.1% | 3.9% | Entered the top 10 |
| 7 | TYRA BIOSCIENCES INC (TYRA) | 3.3% | 3.8% | |
| 8 | WAYSTAR HLDG CORP (WAY) | 5.7% | 3.3% | |
| 9 | IDEAYA BIOSCIENCES INC (IDYA) | 0.0% | 3.1% | Entered the top 10 |
| 10 | ORUKA THERAPEUTICS INC (ORKA) | 0.9% | 2.9% | Entered the top 10 |
| — | ICON PUB LTD CO (ICLR) | 4.9% | 2.6% | Left the top 10 |
| — | DIANTHUS THERAPEUTICS INC (DNTH) | 4.5% | 1.0% | Left the top 10 |
| — | CORCEPT THERAPEUTICS INC (CORT) | 3.9% | 0.0% | Left the top 10 |
| — | LIVANOVA PLC (LIVN) | 3.9% | 0.0% | Left the top 10 |
| — | CELCUITY INC (CELC) | 3.2% | 2.0% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).
Option positions (puts and calls)
Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.
| Activity | Security | Type | Shares before | Shares now | Reported value |
|---|---|---|---|---|---|
| New | SELLAS LIFE SCIENCES GROUP I (SLS) | Put | 0 | 1.23M | $18.2M |
| Exited | CENTENE CORP DEL (CNC) | Put | 100K | 0 | $0 |
| New | HIMS & HERS HEALTH INC (HIMS) | Call | 0 | 75,000 | $2.6M |
| Exited | ELICIO THERAPEUTICS INC (ELTX) | Put | 11,700 | 0 | $0 |
| Exited | OSCAR HEALTH INC (OSCR) | Put | 3,000 | 0 | $0 |